MedPath

Early Mobilisation After Surgery in Patients With Elbow Fracture-dislocation

Not Applicable
Conditions
Elbow Fracture
Early Mobilization
Elbow Stiffnes
Interventions
Other: Experimental early mobilisation
Other: Aktive comparator standrad treatmnet
Registration Number
NCT04648488
Lead Sponsor
Region Östergötland
Brief Summary

The purpose with the study is to evalute if early mobilsation after surgery in patients vid elbow frakture-dislocation may lead to better armfunction and reduce common complications as stiffnes in the elbow. After surgery patients will be randomised to either early mobilisation (exercise treatment 3 Days after surgery) or ordinary treatment (plaster and exercise treatment 3 weeks after surgery).

Detailed Description

In patients with elbow fracture in combinations with dislocation, surgery is often indicated. After surgery the ordinary standard praxis treatment is immobilisation in a plaster for 3 weeks. One common complication is "stiff elbow". Stiffness in the elbow may be due to "heterotopic ossification" which is the abnormal growth of bone in the non-skeletal tissues including muscles or tendons. There is a prospective study that have reported positive results with early mobilisation starting two days after surgery in these patients. However, randomised clinical trials are missing. Therefore our aim was to investigate if early mobilisation may increase elbow function (increased range of motion and decreased pain) and also reduce comlications as stiff elbow compared to ordinary treatment in these patients.

All patients operated with elbow fracture-dislocation at the University hospital in Linköping were asked if the wanted to participate in the study. They had thourough written and oral information about the study. If they agree to participate written informed consent was collected. After surgery patients were randomised to either early mobilisation or to ordinary treatment (standard praxis).

At baseline before surgery or directly after patients filled in some background vatiables such as gender, age social status medical treatment etc They also filled in some self-adminstrated outcome measure in purpuse to evalute upper extremity function and activity and health related quality of Life.

Follow ups with X ray and upper extremity function and activity were at 3 weeks 3 and 12 months with an independent observer.

In beteween these follow ups patient followed the treatment regime (ordinary or early exrecise treatment) and had support from a physiotherapist.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients over 18 years with elbow fracture-dislocation being operated on.

Exclusion Criteria
  • ongoing cancer and earlier radiation therapy in the study arm
  • neurological disease
  • cervcialgia or disc herniation in the neck
  • associated nerv or blodvessel injury
  • dementia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Early mobilisationExperimental early mobilisationPatients will start unloaded exercise treatment 3 days after surgery. They will remove the plaster 5 times every day to perform range of motion exercises.
Standard treatmentAktive comparator standrad treatmnetPatients will have a plaster 3 weeks after surgery and after that start with exercise treatment.
Primary Outcome Measures
NameTimeMethod
Oxford elbow score (OES 0-48 Points)12 month follow up

Evaluating pain, elbowfunction and psychological status

Secondary Outcome Measures
NameTimeMethod
Patient Global impression of changeat three and 12 months

Patient satisfaction

Re-operationin between 3 and 12 month follow up

Number of patients with stiff elbow who need re-operation

Range of motion12 month follow up

elbow range of motion measured with goniometer

Heterotopic ossification3 month follow up

Number of patients with heterotopic ossification verfified by X ray

upper extremity activity scale (0-8)12 month follow up

Activity level Before and after injury

© Copyright 2025. All Rights Reserved by MedPath